Abstract
Background: When children are injured or have surgery, parents can be hesitant to fill opioid prescriptions and youth may be concerned about using these medications to manage pain. Parents cite a myriad of reasons why they worry about their child using opioids. The MedSMA℞T Families intervention, which includes a Family Medication Safety Plan (FMSP), is a tool designed to support families in learning and communicating about safe prescription opioid use in their homes and with health care providers. Objective: This study's first aim was to examine adolescents’ experiences with using the FMSP. The second aim of this study was to identify opportunities for future improvement. Methods: Adolescents, aged 12-18 years, were recruited from April 2021 to October 2021. They were recruited through Qualtrics research panels, email listservs, social media, and snowball sampling. Adolescents reviewed the FMSP and then completed a semistructured follow-up interview with a study team member virtually. The interviews were professionally transcribed verbatim, reviewed by the study team for accuracy, and downloaded into NVivo for analysis. Main themes were identified using content and thematic analysis. Results: Adolescents (N = 65) reviewed the FMSP and participated in the study. Adolescents found the FMSP to be acceptable and useful for prompting discussions with parents about not only opioids, but all medications being used by the youth. Study participants suggested key improvements such as the creation of a kid-friendly or Spanish language version to improve accessibility and uptake by a diverse population of teens. Conclusion: Adolescents reported that the FMSP would be a helpful tool for their families. Implementing this tool at the point of prescribing or dispensing is a potential strategy to reduce the rates of opioid misuse, reduce hesitancy, and allow adolescents more agency regarding their health care and medication management.
| Original language | English |
|---|---|
| Pages (from-to) | 1768-1775.e2 |
| Journal | Journal of the American Pharmacists Association |
| Volume | 63 |
| Issue number | 6 |
| DOIs | |
| State | Published - Nov 1 2023 |
Bibliographical note
Publisher Copyright:© 2023 American Pharmacists Association®
Funding
Funding: This study was supported by the University of Wisconsin-Madison Prevention Research Center Small Grant Award. The University of Wisconsin-Madison Prevention Research Center is a member of the Prevention Research Centers (PRC) Program. It is supported by the Centers for Disease Control and Prevention cooperative agreement number 1U48DP006383 . This study was supported by KL2 grant KL2 TR002374-03 and grant UL1TR002373 to UW ICTR by the Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Funding: This study was supported by the University of Wisconsin-Madison Prevention Research Center Small Grant Award. The University of Wisconsin-Madison Prevention Research Center is a member of the Prevention Research Centers (PRC) Program. It is supported by the Centers for Disease Control and Prevention cooperative agreement number 1U48DP006383. This study was supported by KL2 grant KL2 TR002374-03 and grant UL1TR002373 to UW ICTR by the Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | |
| Centers for Disease Control and Prevention | 1U48DP006383, UL1TR002373, KL2 TR002374-03 |
| National Center for Advancing Translational Sciences (NCATS) | |
| University of Wisconsin-Madison |
ASJC Scopus subject areas
- Pharmacology (nursing)
- Pharmacy
- Pharmacology